Oritavancin (phosphate)

Oritavancin (phosphate)
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
Cay24091-5 5 mg - -

6 - 10 Werktage*

130,00 €
Cay24091-10 10 mg - -

6 - 10 Werktage*

246,00 €
Cay24091-25 25 mg - -

6 - 10 Werktage*

516,00 €
Cay24091-50 50 mg - -

6 - 10 Werktage*

900,00 €
 
Oritavancin is a semisynthetic glycopeptide antibiotic that inhibits the growth of Gram-positive... mehr
Produktinformationen "Oritavancin (phosphate)"
Oritavancin is a semisynthetic glycopeptide antibiotic that inhibits the growth of Gram-positive bacteria. It inhibits transglycosylation and transpeptidation in the bacterial cell wall to disrupt membrane integrity. Oritavancin inhibits the growth of clinical isolates from skin and soft-tissue infections, including methicillin-resistant and -susceptible S. aureus (MRSA, MSSA), vancomycin-resistant and -susceptible E. faecium (VREF, VSRF), as well as other staphylococci, streptococci, and enterococci (MIC90s = =0.008-0.5 mg/L). Oritavancin inhibits growth of S. aureus in a neutropenic-mouse thigh model of infection (ED50 = 0.95 mg/kg for a single dose). It improves survival in a mouse inhalation model of B. anthracis Ames anthrax when administered prophylactically pre- and postexposure and when administered post symptom development. Formulations containing oritavancin have been used to treat bacterial skin infections.Formal Name: (4"R)-22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-N3"-[(4'-chloro[1,1'-biphenyl]-4-yl)methyl]-vancomycin, diphosphate. CAS Number: 192564-14-0. Synonyms: LY 333328. Molecular Formula: C86H97Cl3N10O26 . 2H3PO4. Formula Weight: 1989.1. Purity: >98%. Formulation: (Request formulation change), A crystalline solid. Solubility: DMF: 0.1 mg/ml, DMSO: 0.1 mg/ml. lambdamax: 273 nm. SMILES: OP(O)(O)=O.OP(O)(O)=O.O[C@@H]1[C@@H](O[C@@](O[C@@H](C)[C@@H]2O)([H])C[C@]2(C)NCC3=CC=C(C4=CC=C(Cl)C=C4)C=C3)[C@@H](O[C@H](CO)[C@H]1O)OC5=C(OC6=CC=C([C@H]([C@H]7NC([C@H](NC)CC(C)C)=O)O)C=C6Cl)C=C([C@](NC([C@@H](NC7=O)CC(N)=O)=O)([H])C(N[C@](C8=O)([H])C9=CC%10=C(O)C=C9)=O)C=C5OC%11=CC=C([C@H]([C@](C(N[C@@](C(O)=O)([H])C%12=C%10C(O)=CC(O)=C%12)=O)([H])N8)O[C@]%13([H])O[C@@H](C)[C@H](O)[C@@](C)(N)C%13)C=C%11Cl. InChi Code: InChI=1S/C86H97Cl3N10O26.2H3O4P/c1-35(2)22-51(92-7)77(110)98-67-69(105)42-15-20-55(49(88)24-42)120-57-26-44-27-58(73(57)125-84-74(71(107)70(106)59(34-100)122-84)124-62-32-86(6,76(109)37(4)119-62)93-33-38-8-10-39(11-9-38)40-12-17-45(87)18-13-40)121-56-21-16-43(25-50(56)89)72(123-61-31-85(5,91)75(108)36(3)118-61)68-82(115)97-66(83(116)117)48-28-46(101)29-54(103)63(48)47-23-41(14-19-53(47)102)64(79(112)99-68)96-80(113)65(44)95-78(111)52(30-60(90)104)94-81(67)114,2*1-5(2,3)4/h8-21,23-29,35-37,51-52,. InChi Key: PWTROOMOPLCZHB-BHYQHFGMSA-N.
Schlagworte: LY 333328, (4"R)-22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-N3"-[(4'-chloro[1,1'-biphenyl]-4-yl)methyl]-vancomycin, diphosphate
Hersteller: Cayman Chemical
Hersteller-Nr: 24091

Eigenschaften

Anwendung: Antibacterial glycopeptide antibiotic, Cell wall biosynthesis inhibitor
Konjugat: No
MW: 1989.1 D
Formel: C86H97Cl3N10O26 . 2H3PO4
Reinheit: >98%
Format: Crystalline Solid

Datenbank Information

CAS : 192564-14-0| Passende Produkte

Handhabung & Sicherheit

Lagerung: -20°C
Versand: +20°C (International: -20°C)
Signalwort: Warning
GHS-Piktogramme:
H-Sätze: H317
P-Sätze: P261, P272, P280, P302+352, P321, P333+313, P362+364, P501
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Oritavancin (phosphate)"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen